1
Clinical Trials associated with 4-peptide melanoma vaccine(Eisai Co., Ltd.)Randomized Phase II Study of Multipeptide Vaccination With or Without Regulatory T Cell Depletion Using Ontak in Patients With Metastatic Melanoma
The purpose of this study is to determine if an experimental melanoma vaccine can produce an immune response in patients with metastatic melanoma, and if combining this vaccine with the drug Ontak can improve these immune responses. It is also hoped that this will lead to tumor shrinkage.
100 Clinical Results associated with 4-peptide melanoma vaccine(Eisai Co., Ltd.)
100 Translational Medicine associated with 4-peptide melanoma vaccine(Eisai Co., Ltd.)
100 Patents (Medical) associated with 4-peptide melanoma vaccine(Eisai Co., Ltd.)
100 Deals associated with 4-peptide melanoma vaccine(Eisai Co., Ltd.)